Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L26 pseudogene 37 (*RPL26P37*) is a **pseudogene** related to the gene encoding ribosomal protein L26, which is a component of the large subunit (60S) of the ribosome. Pseudogenes are genetic sequences that resemble functional genes but typically contain mutations or defects (such as stop codons or frameshifts) that prevent them from producing functional proteins. RPL26P37 does not encode a functional protein and has no known biological or disease role. It has been identified as one of many processed ribosomal protein pseudogenes in the human genome, originating via retrotransposition. Unlike true molecular targets such as receptors, enzymes, or transporters, ribosomal protein pseudogenes like RPL26P37 are not considered drug targets and have no therapeutic relevance[2][3][4]. \n\n**Note:** This entry is a pseudogene, not a functional protein or therapeutic target. If a test, screen, or drug refers to "RPL26P37" as a molecular target, this is incorrect and likely due to confusion with the functional ribosomal protein L26 gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L26 pseudogene 37 (RPL26P37).